IDEAS home Printed from https://ideas.repec.org/a/spr/patien/v11y2018i5d10.1007_s40271-018-0319-3.html
   My bibliography  Save this article

Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations

Author

Listed:
  • Amy Simon

    (Alnylam Pharmaceuticals)

  • Farrah Pompilus

    (Modus Outcomes)

  • William Querbes

    (Alnylam Pharmaceuticals)

  • Alex Wei

    (Alnylam Pharmaceuticals)

  • Sara Strzok

    (Modus Outcomes)

  • Craig Penz

    (Alnylam Pharmaceuticals)

  • Desiree Lyon Howe

    (American Porphyria Foundation)

  • Jessica R. Hungate

    (American Porphyria Foundation)

  • Jae B. Kim

    (Alnylam Pharmaceuticals)

  • Sonalee Agarwal

    (Alnylam Pharmaceuticals)

  • Patrick Marquis

    (Modus Outcomes)

Abstract

Objective Acute intermittent porphyria is a rare metabolic disorder that affects heme synthesis. Patients with acute intermittent porphyria may experience acute debilitating neurovisceral attacks that require frequent hospitalizations and negatively impact quality of life. Although clinical aspects of acute intermittent porphyria attacks have been documented, the experience of patients is not well known, particularly for those more severely affected patients who experience frequent attacks. The aim of the present study was to qualitatively characterize the experience of patients with acute intermittent porphyria who have frequent attacks, as well as the impact of the disease on daily living. Methods Patients with acute intermittent porphyria who experience frequent attacks were recruited and took part in 2-h qualitative one-on-one interviews with a semi-structured guide. Interviews were anonymized, transcribed, and coded. The inductive coding approach targeted textual data related to acute intermittent porphyria attack symptoms, chronic symptoms, and the impact of the disease. Saturation analysis was conducted to assess whether the research elicited an adequate account of patients’ experiences. Results In total, 19 patients with acute intermittent porphyria were interviewed (mean age 40 years; 79% female). Eighteen patients (95%) experienced both attack and chronic symptoms. Patients described attacks as the onset of unmanageable symptoms that generally lasted 3–5 days requiring hospitalization and/or treatment. Pain, nausea, and vomiting were considered key attack symptoms; pain, nausea, fatigue, and aspects of neuropathy (e.g., tingling and numbness) were considered key chronic symptoms. Conclusions In this study population of acute intermittent porphyria with frequent attacks, most patients had symptoms during and between attacks. In these patients, acute intermittent porphyria appears to have acute exacerbations as well as chronic day-to-day manifestations, and is not just intermittent as its name implies. As a result, patients reported limitations in their ability to function across multiple domains of their lives on a regular basis and not just during acute attacks.

Suggested Citation

  • Amy Simon & Farrah Pompilus & William Querbes & Alex Wei & Sara Strzok & Craig Penz & Desiree Lyon Howe & Jessica R. Hungate & Jae B. Kim & Sonalee Agarwal & Patrick Marquis, 2018. "Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 11(5), pages 527-537, October.
  • Handle: RePEc:spr:patien:v:11:y:2018:i:5:d:10.1007_s40271-018-0319-3
    DOI: 10.1007/s40271-018-0319-3
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40271-018-0319-3
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40271-018-0319-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:patien:v:11:y:2018:i:5:d:10.1007_s40271-018-0319-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.